• Facebook
  • Twitter
  • Linkedin
  • Instagram
  • Youtube
Metagenics Institute
Your trusted health, nutrition, and personalized lifestyle medicine resource

Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease

Menopausal transition represents a critical period in women’s lives that marks an increase in cardiovascular disease (CVD) risk. Traditional CVD risk factors, such as reduced glucose tolerance, increased blood pressure and endothelial dysfunction, tend to become very present during menopausal transition and post-menopausal years which can partly explain the augmentation in CVD risk among women. The natural decline in oestrogen levels during menopause has been associated with the increase in CVD risk among post-menopausal women. Similarly, VMS are postulated to originate from changes in brain neurotransmitters and instability in the hypothalamic thermoregulatory center brought about by decline in oestrogen level.This case study shows the observational cohort studies or randomised intervention studies were eligible for inclusion if they followed participants prospectively (at least 1 year of follow-up), and reported relevant estimates on the association of any vasomotor symptoms, or other menopausal symptoms.

Download PDF 

Leave a Reply

Related Content

Summary of Practice Guidelines for Prevention of CVD in Individuals with T2D

Summary of Practice Guidelines for Prevention of CVD in Individuals with T2D

Metagenics Institute is a trusted, peer-to-peer, evidence-based educational resource for nutrition and personalized medicine.
At Metagenics Institute, we translate credible research with scientific integrity into innovative and actionable clinical
decision-making. Metagenics Institute supports a diverse practitioner base to optimize patient outcomes by shifting existing paradigms in healthcare. Our mission is to transform healthcare by inspiring and educating practitioners, and their patients, about personalized lifestyle medicine.

About Us | Privacy Policy | Privacy Policy for California Residents
Sponsored by
© 2024 Metagenics Institute. All Rights Reserved